These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4937983)

  • 21. Long-term enzyme replacement therapy in beta-glucuronidase--deficient mice by allogeneic bone marrow transplantation.
    Yatziv S; Weiss L; Morecki S; Fuks Z; Slavin S
    J Lab Clin Med; 1982 Jun; 99(6):792-7. PubMed ID: 7042873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maturation of histocompatibility antigens and host reactivity in the rat.
    Heslop BF
    Transplant Proc; 1969 Mar; 1(1):560-3. PubMed ID: 4944271
    [No Abstract]   [Full Text] [Related]  

  • 23. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation.
    Rufer N; Starobinski M; Chapuis B; Gratwohl A; Jeannet M; Helg C; Roosnek E
    Bone Marrow Transplant; 1998 Nov; 22(9):895-8. PubMed ID: 9827818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation for severe aplastic anemia from HLA identical siblings.
    Bacigalupo A
    Haematologica; 1999 Jan; 84(1):2-4. PubMed ID: 10091385
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunophoretic study of the functional activity of heterologous lymphoid cells transplanted in the early postnatal period].
    Maianskiĭ DN
    Tsitologiia; 1969 Sep; 11(9):1188-93. PubMed ID: 5380067
    [No Abstract]   [Full Text] [Related]  

  • 27. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of endothelial repopulation to explain prolonged renal allograft survival.
    Sinclair RA
    Transplant Proc; 1973 Mar; 5(1):125-8. PubMed ID: 4572089
    [No Abstract]   [Full Text] [Related]  

  • 29. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation. A solution to renal allograft rejection in adult canines.
    Hussey JL
    Wis Med J; 1971 Dec; 70(12):246-7. PubMed ID: 4942933
    [No Abstract]   [Full Text] [Related]  

  • 31. Sex difference in specific and non-specific suppression of non-H-2 allograft responsiveness in mice.
    Nĕmec M
    Folia Biol (Praha); 1971; 17(4):220-6. PubMed ID: 4943668
    [No Abstract]   [Full Text] [Related]  

  • 32. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunobiology of natural killer cells and bone marrow allograft rejection.
    Barao I; Murphy WJ
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
    Rizzieri DA; Koh LP; Long GD; Gasparetto C; Sullivan KM; Horwitz M; Chute J; Smith C; Gong JZ; Lagoo A; Niedzwiecki D; Dowell JM; Waters-Pick B; Liu C; Marshall D; Vredenburgh JJ; Gockerman J; Decastro C; Moore J; Chao NJ
    J Clin Oncol; 2007 Feb; 25(6):690-7. PubMed ID: 17228020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of allograft rejection by induction of specific transplantation tolerance with immunomanipulation using total lymphoid irradiation.
    Slavin S; Gottlieb M; Bieber C; Hoppe RT; Fuks Z; Grumet FC; Kaplan HS; Strober S
    Adv Nephrol Necker Hosp; 1980; 9():209-19. PubMed ID: 6447439
    [No Abstract]   [Full Text] [Related]  

  • 36. [HL-A histocompatibility antigens].
    Plüss HJ
    Schweiz Med Wochenschr; 1971 Oct; 101(42):1495-8. PubMed ID: 4947025
    [No Abstract]   [Full Text] [Related]  

  • 37. Probable graft-vs-graft reaction in an infant after exchange transfusion and marrow transplantation.
    Lauer BA; Githens JH; Hayward AR; Conrad PD; Yanagihara RT; Tubergen DG
    Pediatrics; 1982 Jul; 70(1):43-7. PubMed ID: 6806770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The phenomenon of adaptation: graft or host?
    Warden GD; Reemtsma K; Steinmuller D
    Transplant Proc; 1973 Mar; 5(1):635-9. PubMed ID: 4695955
    [No Abstract]   [Full Text] [Related]  

  • 39. Splenectomy does not enhance engraftment of DLA-nonidentical marrow transplants.
    Raff RF; Loughran TP; Graham T; Pepe M; Johnston B; Sale GE; Storb R
    Exp Hematol; 1993 Feb; 21(2):385-7. PubMed ID: 8425577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow.
    Suzuki H; Patel N; Matthews M; DelRossi AJ; Doolin EJ; Hewitt CW
    J Surg Res; 2000 Apr; 89(2):176-83. PubMed ID: 10729247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.